Patent · US Active

Method for preventing pregnancy

US11896602B2 · kind B2 · utility

2Cited by

40References

20Claims

0Family size

Assignee

ESTETRA SRL · BE

Inventors

Maud Jost · Liège, BE
Glwadys Rausin · Trooz, BE

Key dates

Filing date	Sep 30, 2022
Grant date	Feb 13, 2024
Priority date	—
Expiry date	Sep 30, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method for the management of dysmenorrhea involving administration of an estrogenic component which is preferably selected from the group consisting of estetrol and estetrol-like compounds. Estetrol-like compounds have been surprisingly found to be capable of mitigating dysmenorrhea, either when used alone or in combination with progestogenic components, and this to an extent surpassing the effect obtained with other compositions and with a favourable side-effect profile compared to currently available methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.